219 related articles for article (PubMed ID: 30671724)
1. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
2. Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan.
Lu MY; Wang WC; Hou TC; Kuo CY; Lai YC
Pathol Oncol Res; 2020 Oct; 26(4):2153-2159. PubMed ID: 32157637
[TBL] [Abstract][Full Text] [Related]
3. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
4. Nephroblastic neoplasms.
Khoury JD
Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
[TBL] [Abstract][Full Text] [Related]
5. Stratification of Wilms tumor by genetic and epigenetic analysis.
Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Williams RD; Al-Saadi R; Natrajan R; Mackay A; Chagtai T; Little S; Hing SN; Fenwick K; Ashworth A; Grundy P; Anderson JR; Dome JS; Perlman EJ; Jones C; Pritchard-Jones K
Genes Chromosomes Cancer; 2011 Dec; 50(12):982-95. PubMed ID: 21882282
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization of Wilms' tumor.
Rassekh SR; Rajcan-Separovic E
Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
[TBL] [Abstract][Full Text] [Related]
8. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
[TBL] [Abstract][Full Text] [Related]
9. Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization.
Hawthorn L; Cowell JK
PLoS One; 2011 Apr; 6(4):e18941. PubMed ID: 21544195
[TBL] [Abstract][Full Text] [Related]
10. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
[TBL] [Abstract][Full Text] [Related]
11. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor: an update.
Al-Hussain T; Ali A; Akhtar M
Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in Wilms tumor genetics.
Dome JS; Coppes MJ
Curr Opin Pediatr; 2002 Feb; 14(1):5-11. PubMed ID: 11880727
[TBL] [Abstract][Full Text] [Related]
15. Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome.
Haruta M; Arai Y; Okita H; Tanaka Y; Takimoto T; Sugino RP; Yamada Y; Kamijo T; Oue T; Fukuzawa M; Koshinaga T; Kaneko Y
Neoplasia; 2019 Jan; 21(1):117-131. PubMed ID: 30530054
[TBL] [Abstract][Full Text] [Related]
16. Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms Tumor.
Cabral de Almeida Cardoso L; Rodriguez-Laguna L; Del Carmen Crespo M; Vallespín E; Palomares-Bralo M; Martin-Arenas R; Rueda-Arenas I; Silvestre de Faria PA; ; García-Miguel P; Lapunzina P; Regla Vargas F; Seuanez HN; Martínez-Glez V
PLoS One; 2015; 10(8):e0136812. PubMed ID: 26317783
[TBL] [Abstract][Full Text] [Related]
17. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic anomalies and phenotype alterations in a newly established cell line from Wilms tumor with diffuse anaplasia.
Faussillon M; Murakami I; Bichat M; Telvi L; Jeanpierre C; Nezelof C; Jaubert F; Gogusev J
Cancer Genet Cytogenet; 2008 Jul; 184(1):22-30. PubMed ID: 18558285
[TBL] [Abstract][Full Text] [Related]
19. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
Natrajan R; Warren W; Messahel B; Reis-Filho JS; Brundler MA; Dome JS; Grundy PE; Vujanic G; Pritchard-Jones K; Jones C
J Clin Pathol; 2008 Jan; 61(1):95-102. PubMed ID: 17369505
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
